attralus.comHealthcareFounded: 2019Funding to Date: $145.45MM
Attralus is a biopharmaceutical company focused on creating medicines to improve the lives of patients with systemic amyloidosis. The company uses pan-amyloid removal (PAR) therapeutics to bind and remove toxic amyloid in organs and tissues.
